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ABSTRACT
Objective: To investigate recent respiratory and
influenza-like illnesses (ILIs) in acute myocardial
infarction patients compared with patients hospitalised
for acute non-vascular surgical conditions during the
second wave of the 2009 influenza A H1N1 pandemic.
Design: Case–control study.
Setting: Coronary care unit, acute cardiology and
acute surgical admission wards in a major teaching
hospital in London, UK.
Participants: 134 participants (70 cases and 64
controls) aged ≥40 years hospitalised for acute
myocardial infarction and acute surgical conditions
between 21 September 2009 and 28 February 2010,
frequency-matched for gender, 5-year age-band and
admission week.
Primary exposure: ILI (defined as feeling feverish
with either a cough or sore throat) within the last
month.
Secondary exposures: Acute respiratory illness within
the last month not meeting ILI criteria; nasopharyngeal
and throat swab positive for influenza virus.
Results: 29 of 134 (21.6%) participants reported
respiratory illness within the last month, of whom 13
(9.7%) had illnesses meeting ILI criteria. The most
frequently reported category for timing of respiratory
symptom onset was 8–14 days before admission (31%
of illnesses). Cases were more likely than controls to
report ILI—adjusted OR 3.17 (95% CI 0.61 to 16.47)—
as well as other key respiratory symptoms, and were less
likely to have received influenza vaccination—adjusted
OR 0.46 (95% CI 0.19 to 1.12)—although the
differences were not statistically significant. No swabs
were positive for influenza virus.
Conclusions: Point estimates suggested that recent ILI
was more common in patients hospitalised with acute
myocardial infarction than with acute surgical conditions
during the second wave of the influenza A H1N1
pandemic, and influenza vaccination was associated with
cardioprotection, although the findings were not
statistically significant. The study was underpowered,
partly because the age groups typically affected by acute
myocardial infarction had low rates of infection with the
pandemic influenza strain compared with seasonal
influenza.
INTRODUCTION
Seasonal inﬂuenza can trigger cardiovascular
complications and deaths in vulnerable
populations, especially the elderly and those
ARTICLE SUMMARY
Article focus
▪ Seasonal influenza can trigger cardiovascular
complications, but the cardiac effects of the
2009 influenza pandemic are less clear.
▪ We aimed to investigate recent influenza-like
illness (ILI) in patients hospitalised with acute
myocardial infarction (AMI) and surgical condi-
tions during the 2009 influenza pandemic in
London.
Key messages
▪ In total, 14.3% of patients hospitalised with AMI
(cases) reported recent ILI compared with 4.7%
of patients hospitalised for acute surgical condi-
tions (controls).
▪ Cases were more likely than controls to report a
range of recent respiratory symptoms and less
likely to have received influenza vaccination,
although the differences were not statistically
significant.
▪ The median age of cases with AMI was
63.6 years, whereas the majority of people
infected with pandemic influenza strain nationally
were young.
Strengths and limitations of this study
▪ The study was underpowered to detect an effect,
partly due to low infection rates with the pan-
demic influenza virus in age-groups typically
affected by AMI, but it will inform the design of
future similar studies.
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with underlying medical conditions.1 Evidence to
support the hypothesis that seasonal inﬂuenza may
trigger acute myocardial infarction (AMI) comes from a
range of observational studies incorporating the effects
of different circulating inﬂuenza strains and subtypes.2
In a pandemic situation, however, when there is
global spread of a novel inﬂuenza strain, the clinical and
demographic proﬁles of those affected may change
dramatically.
The most recent inﬂuenza pandemic was caused by an
inﬂuenza A H1N1 strain (H1N1pdm09) that emerged in
Mexico and the USA in April 2009.3 4 The UK experi-
enced several waves of infection with this novel strain—a
ﬁrst wave occurred in spring and summer 2009 followed
by a second wave in the winter of 2009/2010 and a post-
pandemic wave in winter 2010/2011.5 Initial evidence
from the ﬁrst wave in the UK suggested that typical ill-
nesses were mild and affected mainly children and
young people.6 The average age of cases increased over
subsequent waves of the pandemic,7 but it is unclear
how this affected clinical illness proﬁles. Vaccination
coverage did not reach high levels until the postpan-
demic season.
There have been reports of myocarditis, myocardial
injury and left-ventricular systolic dysfunction, which
may be reversible, in patients with severe
H1N1pdm09.8 9 It has been suggested that H1N1pdm09
was associated with higher rates of extrapulmonary com-
plications than seasonal inﬂuenza,10 but this is difﬁcult
to compare as surveillance of severe inﬂuenza-related
disease was greatly enhanced during the pandemic. A
recent mathematical modelling study estimated that glo-
bally there were 83 300 cardiovascular deaths associated
with the ﬁrst 12 months of H1N1pdm09 circulation in
adults aged >17 years,11 but the contribution of myocar-
dial infarction deaths to this ﬁgure is unknown.
In this study, we aimed to investigate whether patients
hospitalised for AMI during the winter wave of the inﬂu-
enza A H1N1 pandemic were more likely than surgical
patients to have experienced recent inﬂuenza-like illness
(ILI) or acute respiratory illness, or to have concurrent
PCR positive inﬂuenza or evidence of inﬂuenza A IgA
antibodies in sera.
METHODS
Setting, design and participants
This was an observational case–control study carried out
in hospital inpatients at the Royal Free London NHS
Foundation Trust between 21 September 2009 and 28
February 2010. Cases were patients aged ≥40 years who
had experienced an AMI (deﬁned as a rise in troponin
T with ischaemic symptoms and/or typical ECG
changes, or by angiographic evidence of acute coronary
artery thrombosis during primary percutaneous coron-
ary intervention). Controls were patients aged ≥40 years
admitted with an acute surgical condition such as
appendicitis, bowel or urinary obstruction and no
history of myocardial infarction within the past month.
These patients were chosen as controls because their
admissions were considered unlikely to be inﬂuenced by
recent ILI. Cases and controls were frequency matched
for gender, age-group in 5-year age-bands and week of
admission. All were English-speaking and able to provide
written informed consent. The study size was based on
numbers of eligible patients hospitalised during the
inﬂuenza circulation period.
Exposures
The main exposure was recent ILI, deﬁned as a history
of feeling feverish with either a cough or sore throat
within the last month. We also used the exposure recent
acute respiratory infection to capture a history of respira-
tory illness within the last month with any of the follow-
ing symptoms—fever, chills, dry cough, productive
cough, myalgia, rhinorrhoea, blocked nose, sore throat,
wheeze, earache and fatigue—that did not meet the cri-
teria for ILI. Additional exposures were nasopharyngeal
and throat swabs testing positive for inﬂuenza by real-
time PCR, the presence of IgA antibodies to inﬂuenza A
in serum samples and self-reported inﬂuenza vaccination
status.
Data sources and measurement
We used a questionnaire to investigate recent respiratory
and ILI as well as to capture data on demographics,
medical history and inﬂuenza vaccination status.
Information on inﬂuenza vaccination status was col-
lected as ‘vaccinated this year (from September 2009)’,
‘vaccinated last year (September 2008—August 2009)’,
‘vaccinated 2–5 years ago’, ‘vaccinated >5 years ago’ and
‘never vaccinated’. Vaccination status was then recate-
gorised as a binary variable comprising ‘vaccinated this
year’ and ‘unvaccinated’, which included all other cat-
egories, to recognise that vaccinations in previous
seasons would not protect against the new circulating
pandemic inﬂuenza strain. Medical records were
reviewed for details of the current admission and to
conﬁrm data on potential confounding factors.
Combined nasopharyngeal and throat swabs were taken
from each participant, placed in viral transport medium
and transported to the laboratory for storage at −80°C.
Samples were tested for the presence of inﬂuenza virus
RNA using a validated in-house real-time PCR with a
lower limit of detection of one RNA copy per reaction,
as previously described.12 A single serum sample was
taken for quantiﬁcation of IgA antibodies to inﬂuenza A
as a marker of recent exposure (as IgA levels peak at
around 2 weeks after exposure and reach the baseline by
around 4–6 weeks). Serum samples were centrifuged,
frozen at −80°C and batch tested using a commercially
available ELISA for inﬂuenza A IgA (Biosupply UK, cat
no. RE56501). Antibody concentrations were initially
explored as a continuous variable, then categorised into
‘positive’ (>12 U/ml), ‘equivocal’ (8–12 U/ml) and
‘negative’ (>8 U/ml) categories based on standard
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laboratory thresholds. Equivocal results were dropped
for analyses.
Statistical methods
All analyses were carried out using Stata (Stata Statistical
Software: Release 12. College Station, Texas, USA:
StataCorp LP). Baseline comparability between cases
and controls was assessed with χ² tests. Characteristics of
participants with and without missing data were also
compared using χ² tests to assess any risk of bias asso-
ciated with missing data. We used multivariable logistic
regression analysis to investigate associations between
recent ILI or acute respiratory illness exposures and
case/control status, controlling for the frequency-
matching factors age-group, gender and month of
admission and inﬂuenza vaccination status as an a priori
confounder (all models) as well as for other potential
confounding factors. An additional multivariable model
in which inﬂuenza vaccination status was the main
exposure was generated using the same approach.
Potential confounders were examined using a backward-
stepwise approach whereby factors independently asso-
ciated with both exposure and outcome were included
in models and likelihood ratio tests used to assess the
effect of removing each one sequentially. If p values
from likelihood ratio tests were <0.1, then factors were
retained in the model.
RESULTS
Characteristics of study participants
In total, 134 participants were recruited, who comprised
70 cases from 106 approached (acceptance rate 66%)
and 64 controls from 95 approached (acceptance rate
67%). Reasons for non-participation included lack of
time, unwillingness to experience additional procedures
and feeling tired or unwell. The median age of partici-
pants was 63.6 years (IQR 53.3–72.6), of whom 21%
were women. Cases were more likely to be of Asian or
Asian British ethnicity (p=0.016), to have a previous
history of myocardial infarction (p=0.04) or a family
history of myocardial infarction (p<0.001) than controls.
Of the 70 patients hospitalised for AMI, 48 (68.5%) met
criteria for ST-elevation myocardial infarction, 17
(24.3%) had a non-ST-elevation myocardial infarction
and in 5 (7.1%) cases the subtype of myocardial infarc-
tion was unspeciﬁed. Control patients were admitted
with a range of acute non-vascular surgical presentations
that included colorectal, urological and orthopaedic
conditions (table 1).
Timing of participants’ admissions in relation to national
influenza circulation
A comparison of study participants’ dates of admission
with national rates of general practitioner (GP) consulta-
tions for ILI based on RCGP surveillance data is shown
in ﬁgure 1. The peak week for ILI consultations in
England was week 43 (ending 25 October 2009) when
the rate was 42.8/100 000. This was also the peak week
for inﬂuenza virus circulation according to data from
virological sentinel surveillance schemes, when the pro-
portion of positive samples reached 41.2%. Our recruit-
ment period spanned this period of peak inﬂuenza
circulation.
Recent respiratory and ILI
Seventeen cases (24.3%) and 12 controls (18.8%)
reported respiratory illness in the month preceding hos-
pital admission. Thirteen illnesses—reported by 10 cases
(14.3%) and 3 controls (4.7%)—met criteria for ILI
(deﬁned as feeling feverish with a cough and/or sore
throat). The most frequently reported category for the
timing of respiratory symptom onset was 8–14 days
before admission (31% of illnesses). Four to seven days
were the most frequently reported category for length of
illness (37.9% of illnesses). Symptom proﬁles of partici-
pants reporting recent respiratory illness are shown in
ﬁgure 2. No swabs tested positive for inﬂuenza virus
nucleic acid. Serum samples were available on 113 of
134 participants (84.3%). There were no signiﬁcant dif-
ferences in characteristics of participants with and
without missing serum samples (data not shown).
Twenty-ﬁve cases (43.1%) and 28 controls (50.9%)
tested positive for serum inﬂuenza A IgA antibodies.
Sixty-two per cent of participants who were seropositive
had received inﬂuenza vaccination during the study
period compared with 31% of seronegative participants.
Overall, 44% of participants were vaccinated. The pro-
portion of participants recruited in each month who
were vaccinated increased from 0% in September 2009
to 29.6% in October 2009, 44.8% in November 2009,
55% in December 2009, 72% in January 2010 and was
50% in February 2010.
Cases were more likely to have reported ILI than con-
trols—adjusted OR 3.17 (95% CI 0.61 to 16.47)—as well
as other key respiratory illness symptoms, although
differences were not statistically signiﬁcant. Results
from this logistic regression analysis are summarised in
table 2. There was also a trend towards a protective
effect of inﬂuenza vaccination against myocardial infarc-
tion—adjusted OR 0.46 (95% CI 0.19 to 1.12)—after
controlling for age group, gender, month of admission
and personal history of AMI.
DISCUSSION
The study was supportive of the hypothesis that recent
respiratory illnesses and, in particular, ILIs occurring
during the second wave of the inﬂuenza A H1N1 pan-
demic were more common in patients hospitalised with
AMI than with acute surgical conditions. Inﬂuenza vac-
cination was also associated with protection against myo-
cardial infarction, although differences were not
statistically signiﬁcant. While we had hypothesised that
more adults would be infected during the second
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pandemic wave due to the expected upward shift in age
distribution of infections, the national rates of ILI
remained low,5 especially in age groups typically affected
by AMI. The study was therefore underpowered to
detect an effect, partly due to the limited numbers of
infections among participants.
Using self-reported recent respiratory illness and ILI
as exposures introduced the possibility of reporting or
recall bias. Nonetheless, this method allows greater sen-
sitivity to detect recent respiratory symptoms than
relying on reports of medically attended illnesses, which
comprise only a small minority of inﬂuenza cases.13 As
cases and controls were frequency matched in the week
of admission, external factors such as media coverage of
the inﬂuenza pandemic should not have had a differen-
tial effect on respiratory illness reporting. We chose to
test both nasopharyngeal and throat swabs to increase
the sensitivity of virus detection. It was perhaps unsur-
prising, however, that none of the nasopharyngeal and
throat swabs were positive for inﬂuenza virus given (1)
the low rates of infection in this age-group5 and (2) that
the majority of viral shedding in inﬂuenza occurs in the
ﬁrst 2–3 days after symptom onset,14 whereas most of the
reported respiratory symptoms in study participants
Table 1 Characteristics of study participants (n=134)
Characteristic Category Cases (n=70) Controls (n=64) p Value
Age group
40–49 8 (11.4) 13 (20.3) 0.61
50–59 19 (27.1) 18 (28.1)
60–69 19 (27.1) 15 (23.4)
70–79 17 (24.3) 11 (17.2)
80+ 7 (10.0) 7 (10.9)
Gender
Female 13 (18.6) 15 (23.4) 0.49
Male 57 (81.4) 49 (76.6)
Admission month
September 8 (11.4) 7 (10.9) 0.92
October 12 (17.1) 15 (23.4)
November 15 (21.4) 14 (21.9)
December 10 (14.3) 10 (15.6)
January 14 (20.0) 11 (17.2)
February 11 (15.7) 7 (10.9)
Ethnicity
Asian or Asian British 18 (25.7) 6 (9.4) 0.03
Black or Black British 2 (2.9) 0 (0.0)
Mixed 0 (0.0) 1 (1.6)
White 50 (71.4) 57 (89.1)
BMI category
18.5–24.9 20 (30.8) 23 (39.0) 0.41
25.0–29.9 36 (55.4) 24 (40.7)
30.0–39.9 8 (12.3) 10 (17.0)
40.0–max 1 (1.5) 2 (3.4)
Smoker
No never 22 (31.4) 23 (35.9) 0.77
Yes current 27 (38.6) 21 (32.8)
Yes ex 21 (30.0) 20 (31.3)
Medical history
Hypercholesterolaemia* 34 (48.6) 28 (43.8) 0.58
Diabetes 14 (20.0) 12 (18.8) 0.86
Hypertension 37 (52.9) 26 (40.6) 0.16
AMI 14 (20.0) 5 (7.8) 0.04
Stroke 1 (1.4) 4 (6.3) 0.14
Family history
AMI 43 (61.4) 19 (29.7) <0.001
Stroke 5 (7.1) 6 (9.4) 0.64
Influenza vaccination status†
Vaccinated 30 (42.9) 29 (45.3) 0.78
*28 cases (40%) and 25 controls (39%) with hypercholesterolaemia reported current statin use.
†‘Vaccinated’ refers to receiving influenza vaccination in the current vaccination year (since September 2009).
AMI, acute myocardial infarction; BMI, body mass index.
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occurred 8–14 days before admission. Based on our ﬁnd-
ings, it seems unlikely that any delayed cardiac effect of
inﬂuenza is linked to ongoing or prolonged virus repli-
cation or shedding in the respiratory tract. Inﬂuenza ser-
ology is difﬁcult to interpret in vaccinated participants
as it not possible to distinguish antibody rises caused by
infection from those caused by vaccination. Validation of
the IgA assay used suggests that it has acceptable sensitiv-
ity and speciﬁcity to detect recent seasonal inﬂuenza A
infection,15 but its effect with the pandemic strain
H1N1pdm09 is unclear. It has previously been noted
that serological studies carried out during the 2009
inﬂuenza pandemic were severely hampered by cross-
reactivity both with the vaccine and with the seasonal
inﬂuenza strains.7
Previous observational studies using large electronic
primary care databases have found an association
between GP consultation for acute respiratory infection
in the previous month and risk of AMI.16–18 Although
studies were conducted over different time periods, they
encompassed the effect of varying seasonal inﬂuenza
strains. In the present study, we controlled for important
potential confounders such as inﬂuenza vaccination
status, and showed that statin use was equally prevalent
in cases and controls. We did not, however, have com-
plete data on other drugs that have been hypothesised
to have immune-regulatory effects (such as ACE inhibi-
tors, angiotensin receptor blockers, metformin, glita-
zones and ﬁbrates). If these agents reduce the
likelihood of people experiencing ILI, and were more
commonly used in cases than controls, they could poten-
tially have confounded the relationship between ILI and
AMI. It was reassuring, however, that our results were
consistent with those obtained in our recent self-
controlled case series study—a design that implicitly con-
trols for ﬁxed confounders. In this study, we used linked
primary care and cardiac disease registry records from
3927 patients from 2003–2009, which also included
acute respiratory infection consultations occurring
during the ﬁrst wave of H1N1pdm09 circulation.19 We
Figure 1 Number of study
participants admitted by influenza
surveillance week compared with
weekly influenza-like illness rates
per 100 000 based on national
RCGP surveillance data.
Figure 2 Percentage of cases
(n=70) and controls (n=64)
reporting various symptoms
during respiratory illness.
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found an incidence ratio for AMI of 4.19 (95% CI 3.18
to 5.53) in the ﬁrst 1–3 days after acute respiratory infec-
tion, with the risk falling to baseline after 28 days.19
Elderly people and those consulting for an infection
judged most likely to be due to inﬂuenza were at great-
est risk. During the 2009 inﬂuenza, pandemic people
with underlying cardiovascular disease were much more
likely to be hospitalised13 and to die20 from a range of
causes attributable to pandemic inﬂuenza. Although
most deaths from H1N1pdm09 occurred in younger
people, this was partly a function of the age distribution
of infections: in the UK, the case death rate in the
elderly was much higher than in younger age-groups,5
but overall, the numbers of deaths were small as few
elderly people were infected.
Various biological mechanisms are proposed to under-
lie a relationship between inﬂuenza or acute respiratory
infection and myocardial infarction.21 Acute respiratory
infections may result in a host of acute inﬂammatory
and haemostatic effects leading to systemic inﬂamma-
tion, altered plasma viscosity, coagulability and haemo-
dynamic changes22 as well as promoting local
endothelial dysfunction, coronary inﬂammation and
plaque rupture.23 Immobility associated with bedrest
and dehydration might potentiate these processes.
In conclusion, this study suggests that recent ILI occur-
ring during the 2009 inﬂuenza pandemic was more
common in AMI patients. Taken in the context of previ-
ous work, this helps to support the hypothesis that, as
with other inﬂuenza strains, H1N1pdm09 could poten-
tially trigger AMI in vulnerable groups. It is likely,
however, that the effect is not speciﬁc to inﬂuenza and
could have also been caused by other viruses circulating
at the time. The population impact of H1N1pdm09 on
rates of hospitalisations and deaths from myocardial
infarction is also likely to have been relatively low given
the mismatch between the ages of those typically
affected by H1N1pdm09 and acute coronary events as
well as the relatively mild clinical effects of this inﬂuenza
strain.
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